Better Marijuana Stock to Buy: Cronos Group or Canopy Growth?

Cannabis companies continue to remain volatile in 2020. Over the last 20 months, they have been impacted by valuation issues, a thriving black market, lower than expected demand, high inventory levels, mounting losses, health issues from the vaping scandals, and much more.

The investor euphoria that surrounded cannabis stocks when Canada legalized marijuana for recreational use seems like a distant dream. However, there are reasons to be bullish on this industry. The marijuana sector is still at a nascent stage and is expected to grow at a rapid pace in the upcoming decade. The extended market sell-off also provides investors with an opportunity to buy growth stocks at a lower valuation.

Keeping this mind, let's take a look at whether Cronos Group (NASDAQ: CRON) or Canopy Growth (NYSE: CGC) is a better buy right now.

Source Fool.com